Abbas Tafakhori
Abbas Tafakhori
Iranian Center of Neurological Research, Tehran University of Medical Sciences
Verified email at
Cited by
Cited by
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial
M Jafarinia, M Afarideh, A Tafakhori, M Arbabi, A Ghajar, AA Noorbala, ...
Journal of affective disorders 204, 1-8, 2016
An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic …
A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ...
Neurological Sciences 36 (7), 1121-1126, 2015
A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations
S Taghavi, R Chaouni, A Tafakhori, LJ Azcona, SG Firouzabadi, ...
Molecular neurobiology 55 (4), 3477-3489, 2018
Early versus late spinal decompression surgery in treatment of traumatic spinal cord injuries; a systematic review and meta-analysis
M Yousefifard, V Rahimi-Movaghar, M Baikpour, P Ghelichkhani, ...
Emergency 5 (1), 2017
Effects of early intervention of swallowing therapy on recovery from dysphagia following stroke
J Bakhtiyari, P Sarraf, N Nakhostin-Ansari, A Tafakhori, J Logemann, ...
Iranian journal of neurology 14 (3), 119, 2015
The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients
M Abdolahi, A Tafakhori, M Togha, AA Okhovat, F Siassi, MR Eshraghian, ...
Immunogenetics 69 (6), 371-378, 2017
Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial
M Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ...
Neurotherapeutics 15 (2), 430-438, 2018
Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
E Agah, A Zardoui, A Saghazadeh, M Ahmadi, A Tafakhori, N Rezaei
PloS one 13 (1), e0190252, 2018
Memantine for prophylactic treatment of migraine without aura: A randomized double‐blind placebo‐controlled study
R Noruzzadeh, A Modabbernia, V Aghamollaii, M Ghaffarpour, ...
Headache: The Journal of Head and Face Pain 56 (1), 95-103, 2016
A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine …
M Abdolahi, P Sarraf, MH Javanbakht, NM Honarvar, M Hatami, N Soveyd, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018
Sensing of Alzheimer’s disease and multiple sclerosis using nano-bio interfaces
MJ Hajipour, F Ghasemi, H Aghaverdi, M Raoufi, U Linne, F Atyabi, ...
Journal of Alzheimer's Disease 59 (4), 1187-1202, 2017
Identification of a Large DNAJB2 Deletion in a Family with Spinal Muscular Atrophy and Parkinsonism
E Sanchez, H Darvish, R Mesias, S Taghavi, SG Firouzabadi, RH Walker, ...
Human mutation 37 (11), 1180-1189, 2016
Serum and CSF PDGF‐AA and FGF‐2 in relapsing‐remitting multiple sclerosis: a case–control study
MH Harirchian, AH Tekieh, A Modabbernia, V Aghamollaii, A Tafakhori, ...
European Journal of Neurology, 2012
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
S Arabzadeh, E Hakkikazazi, N Shahmansouri, A Tafakhori, A Ghajar, ...
Journal of affective disorders 235, 236-241, 2018
The combined effects of ω-3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patients
N Soveyd, M Abdolahi, M Djalali, M Hatami, A Tafakhori, P Sarraf, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017
Validation of the Persian version of the Brief Pain Inventory (BPI-P) in chronic pain patients
H Majedi, SS Dehghani, S Soleyman-Jahi, SAE Meibodi, ...
Journal of pain and symptom management 54 (1), 132-138. e2, 2017
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature
A Nejati, Z Shoja, S Shahmahmoodi, A Tafakhori, Y Mollaei-Kandelous, ...
Medical microbiology and immunology 205 (2), 143-154, 2016
Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population
L Haghnejad, B Emamalizadeh, J Jamshidi, AZ Bidoki, H Ghaedi, ...
Journal of the neurological sciences 355 (1-2), 72-74, 2015
Transplantation of olfactory ensheathing cells on functional recovery and neuropathic pain after spinal cord injury; systematic review and meta-analysis
B Nakhjavan-Shahraki, M Yousefifard, V Rahimi-Movaghar, M Baikpour, ...
Scientific reports 8 (1), 1-12, 2018
Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders
B Fallahi, A Esmaeili, D Beiki, S Oveisgharan, H Noorollahi-Moghaddam, ...
Annals of nuclear medicine 30 (2), 153-162, 2016
The system can't perform the operation now. Try again later.
Articles 1–20